Welcome to our dedicated page for Cohen Company SEC filings (Ticker: COHN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cohen & Company Inc (COHN) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cohen & Company is a Maryland corporation with its common stock listed on the NYSE American, and it reports under Commission File Number 1-32026. Its filings give detailed insight into the performance and structure of its Capital Markets, Asset Management, and Principal Investing segments.
Investors can review Current Reports on Form 8-K that Cohen & Company files to announce material events. Recent 8-K filings have covered quarterly financial results, including revenue, net income, and segment performance, as well as special common stock dividends. Other 8-Ks discuss SPAC-related transactions, such as business combination agreements and closings involving sponsored SPACs, the conversion and transfer restrictions of founder shares, and the impact of these transactions on the company’s holdings. Additional 8-Ks address items like amendments to loan agreements and the sale of legacy Alesco CDO management contracts.
Through this page, users can also locate references to the company’s periodic reports, such as Forms 10-Q and 10-K, which are cited in 8-Ks for more detailed financial statements, risk factors, and management’s discussion and analysis. These filings explain how Cohen & Company’s fixed income trading, new issue and advisory activities, asset management mandates, and principal investments contribute to its financial condition and results of operations.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly understand the significance of earnings releases, special dividends, SPAC transactions, and financing arrangements. Real-time updates from EDGAR, combined with structured access to exhibits and Form 4 insider-related information where available, make this page a practical starting point for analyzing COHN’s regulatory disclosures.
Lester R. Brafman has filed Amendment No. 5 to his Schedule 13D for Cohen & Co Inc., updating his reported ownership of the company’s common stock. He now reports beneficial ownership of 315,702 shares, representing 15.51% of the outstanding common stock, based on 2,035,863 shares outstanding as of November 28, 2025.
The filing explains that this total includes 40,000 restricted shares granted under the company’s 2020 Long-Term Incentive Plan, whose restrictions will expire on January 31, 2026. When those restrictions lapse, Brafman will have full voting and dispositive power over these 40,000 shares, and he is therefore deemed the beneficial owner of them within 60 days of the filing date.
Daniel G. Cohen reports an updated beneficial ownership position in Cohen & Company Inc., reflecting control of 4,375,648 shares of common stock, or 77.41% of the class based on the company’s stated share count and redeemable units. This includes shares he holds directly, through entities he controls, and through family trusts.
The update also captures equity awards granted under the 2020 Long-Term Incentive Plan. A total of 1,011,000 restricted LLC units will have restrictions lapse on January 31, 2026, allowing redemption into 101,100 shares of common stock at a 10-to-1 unit-to-share ratio. Because these units are redeemable within 60 days of the reporting date, the related shares are treated as beneficially owned, further consolidating Cohen’s majority position.
Cohen & Company Inc. (COHN) reported stronger Q3 2025 results. Total revenues were $84.2 million versus $31.7 million a year ago, driven by new issue and advisory revenue of $228.0 million and net trading revenue of $13.6 million, partly offset by a principal transactions and other loss of $159.3 million. Operating income was $21.8 million versus $7.2 million. Net income attributable to Cohen & Company Inc. was $4.6 million, with diluted EPS of $2.58 versus $1.31.
For the nine months ended September 30, 2025, revenues were $172.8 million versus $61.1 million, and diluted EPS was $3.61 versus $1.12. On the balance sheet, cash and cash equivalents were $54.7 million (up from $19.6 million at December 31, 2024), total assets were $773.9 million, and total equity was $101.1 million. As of October 28, 2025, there were 2,035,863 common shares outstanding. The company reported $1.4 billion AUM as of September 30, 2025.
Cohen & Company Inc. (COHN) furnished an 8‑K stating it issued a press release announcing financial results for the third quarter ended September 30, 2025. The company attached the release as Exhibit 99.1. The information is provided for disclosure purposes and, as stated, shall not be deemed “filed” under Section 18 of the Exchange Act nor incorporated by reference except as specifically noted. COHN’s common stock trades on the NYSE American under the symbol COHN.
Cohen & Company Inc. (COHN) Q2-25 10-Q highlights
- Revenue rebound: Q2 sales jumped to $59.9 M from $10.8 M in Q2-24, driven by New Issue & Advisory fees ($37.4 M vs. $6.5 M) and stronger Net Trading ($10.8 M vs. $8.8 M).
- Return to profit: Net income attributable to COHN was $1.4 M (diluted EPS $0.81) versus a $2.3 M loss (-$1.47) a year ago. Six-month net income reached $1.7 M (EPS $1.00) against a $0.3 M loss in 1H-24.
- Margins improve: Operating income rose to $7.5 M from a $6.4 M loss; operating margin 12.5 % vs. -59.0 %.
- Cost pressures: Compensation & benefits surged to $44.3 M (74 % of revenue) from $10.7 M, reflecting revenue-tied payouts and equity awards.
- Balance sheet: Assets grew to $1.13 B (from $971 M) largely via resale agreements. Debt declined to $32.6 M (-$2.3 M); cash rose to $26.0 M.
- Equity: Book value increased to $92.5 M vs. $90.3 M; tangible common equity $43.4 M.
- Cash flow: Operating cash inflow of $7.0 M vs. $0.9 M in 1H-24; investing provided $5.2 M; financing used $6.4 M (dividends, note repayment).
- Other items: $0.8 M gain on sale of management contracts; equity-method loss Q2 (-$1.4 M) after large loss Q2-24 (-$6.0 M).
Overall, robust advisory revenue restored profitability but carries higher compensation expense; leverage remains concentrated in repo funding.
Cohen & Company Inc. (NYSE American: COHN) filed a Form 8-K to disclose that its affiliated special-purpose acquisition company, Columbus Circle Capital Corp. I (NASDAQ: CCCMU), signed a definitive Business Combination Agreement on 23 June 2025 with ProCap BTC, ProCap Financial and related entities. The agreement would result in ProCap Financial becoming a publicly traded company.
Transaction structure and funding:
- The SPAC completed its May 19 IPO of 25 million units, including 3 million from the underwriters’ over-allotment.
- Concurrent with signing, qualified investors purchased ≈ $516.5 million of non-voting preferred units in ProCap BTC.
- Investors also committed to $235 million in convertible notes to be issued by ProCap Financial at closing.
- Net proceeds are earmarked to acquire bitcoin and for working-capital needs.
Cohen & Company involvement:
- The operating subsidiary (Cohen & Company, LLC) is a managing member of the SPAC’s sponsor, which holds 8.33 million founder shares; ≈ 2.15 million are currently allocated to the operating subsidiary, subject to final determination at closing.
- Its capital-markets division (CCM) served as lead underwriter in the IPO and co-placement agent for both the preferred equity and convertible-note financings.
Next steps: The SPAC and ProCap Financial will file an S-4 registration statement containing a proxy/prospectus; shareholder approval and customary closing conditions remain outstanding. If consummated, each founder share will convert into one share of ProCap Financial.
The filing reiterates extensive forward-looking-statement warnings and highlights standard risk factors, including market volatility, bitcoin price risk, regulatory scrutiny, and dependence on successful deal completion.
Cohen & Company (NYSE:COHN) filed a Form 8-K to report that its broker-dealer subsidiary, J.V.B. Financial Group, LLC, executed a Third Amendment to its existing $15 million revolving loan agreement with Byline Bank.
The amendment extends the maturity and final borrowing date by one year—moving from 18 June 2025 to 18 June 2026—and reduces the required Excess Net Capital covenant to $30 million from $40 million. No other economic terms, including the overall commitment size, interest provisions, or collateral requirements, were changed.
Management therefore preserves access to committed liquidity for an additional 12 months while simultaneously freeing up to $10 million of regulatory capital that can be redeployed within the broker-dealer. The full text of the amendment is provided as Exhibit 10.1. There were no accompanying financial statements, legal proceedings, or risk factor updates included in the filing.